21st week of 2019 patent applcation highlights part 11 |
Patent application number | Title | Published |
20190151353 | POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF | 2019-05-23 |
20190151354 | THERAPEUTIC GAS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS | 2019-05-23 |
20190151355 | COMPOSITIONS CONTAINING POLYMERIC SULFUR AND USES THEREOF | 2019-05-23 |
20190151356 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH INFECTION AND/OR INFLAMMATION | 2019-05-23 |
20190151357 | MATERIALS AND METHODS FOR PRODUCING AND USING MITOCHONDRIAL PREPARATIONS | 2019-05-23 |
20190151358 | P53 SILENCED ENDOTHELIAL PROGENITOR CELLS FOR DIABETES | 2019-05-23 |
20190151359 | CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF | 2019-05-23 |
20190151360 | GALECTIN-3 PLASMAPHERESIS THERAPY | 2019-05-23 |
20190151361 | METHODS OF ADMINISTERING CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY | 2019-05-23 |
20190151362 | COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY | 2019-05-23 |
20190151363 | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | 2019-05-23 |
20190151364 | GENETICALLY MODIFIED T LYMPHOCYTES | 2019-05-23 |
20190151365 | COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS | 2019-05-23 |
20190151366 | COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE | 2019-05-23 |
20190151367 | TREATING OPTIC NEURITIS WITH INDUCED PLURIPOTENT STEM CELL-DERIVED OLIGODENDROCYTE PRECURSOR CELLS | 2019-05-23 |
20190151368 | Treatment Of Vocal Cords With Autologous Dermal Fibroblast Formulation | 2019-05-23 |
20190151369 | Engineered Stem Cell Therapy for Cardiac Repair | 2019-05-23 |
20190151370 | EXTRACT AND FORMULATION INCLUDING EXTRACT | 2019-05-23 |
20190151371 | PROCESS FOR CONTINUOUS CELL CULTURE OF ISLET CELLS | 2019-05-23 |
20190151372 | PERICYTE CELL EXOSOMES | 2019-05-23 |
20190151373 | METHOD OF ISOLATING CELLS FOR THERAPY AND PROPHYLAXIS | 2019-05-23 |
20190151374 | CONDITIONED STEM CELL-DERIVED EXTRACT | 2019-05-23 |
20190151375 | Extract effective in treating drug addiction and preparation method therefor | 2019-05-23 |
20190151376 | TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA | 2019-05-23 |
20190151377 | METHOD FOR CULTURING AND PRESERVING EUBACTERIUM HALLII | 2019-05-23 |
20190151378 | PROBIOTIC COMPOSITION AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF GALECTIN-3 DEPENDENT DISORDER | 2019-05-23 |
20190151379 | ENZYME COMPOSITION AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF GALECTIN-3 DEPENDENT DISORDERS | 2019-05-23 |
20190151380 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2019-05-23 |
20190151381 | UPPER GASTROINTESTINAL FLORA-IMPROVING AGENT | 2019-05-23 |
20190151382 | PROBIOTIC BACTERIA-DIRECTED PREVENTION OR TREATMENT OF FUNGAL INFECTION | 2019-05-23 |
20190151383 | SIGNAL-SMART ONCOLYTIC VIRUSES IN TREATMENT OF HUMAN CANCERS | 2019-05-23 |
20190151384 | Medicinal Composition for Treating Fibrosis | 2019-05-23 |
20190151385 | Hair Loss Treatment Compositions and Methods of Making and Using Same | 2019-05-23 |
20190151386 | COMPOSITIONS AND METHODS TO RELIEVE CHRONIC DISEASES SYMPTOMS | 2019-05-23 |
20190151387 | BOTANICAL FORMULATIONS | 2019-05-23 |
20190151388 | BOTANICAL TINCTURES | 2019-05-23 |
20190151389 | DETOXIFYING COMPOSITION CONTAINING NEW GREEN EXTRACT AS ACTIVE INGREDIENT | 2019-05-23 |
20190151390 | PERILLA EXTRACT COMPOSITION | 2019-05-23 |
20190151391 | COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASE, CONTAINING OIL OF LITSEA JAPONICA AS ACTIVE INGREDIENT, AND METHOD FOR PREPARING SAME | 2019-05-23 |
20190151393 | Tobacco Leaf Extract and Use Thereof for the Treatment of Tobacco Addiction | 2019-05-23 |
20190151394 | Prebiotic Acne Treatment | 2019-05-23 |
20190151395 | DAPHNE LAUREOLA EXTRACTS IN THE TREATMENT OF DERMOPATHIES | 2019-05-23 |
20190151396 | COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF OSTEOARTICULAR INFLAMMATION AND PAIN AND CARTILAGE DAMAGE | 2019-05-23 |
20190151397 | COMPOSITIONS FOR ENHANCING BRAIN ACTIVITY | 2019-05-23 |
20190151398 | Pharmaceutical Composition Comprising Cannabidiol (CBD) and Lecithin | 2019-05-23 |
20190151399 | METHODS FOR STIMULATING CONVERSION OF BODY FAT INTO MUSCLE MASS | 2019-05-23 |
20190151400 | PROTEASE TRANSITION STATE INHIBITOR PRODRUGS | 2019-05-23 |
20190151401 | Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions | 2019-05-23 |
20190151402 | METHOD OF TREATING CANCER CELLS | 2019-05-23 |
20190151403 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | 2019-05-23 |
20190151404 | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEEASE | 2019-05-23 |
20190151405 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | 2019-05-23 |
20190151406 | Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases | 2019-05-23 |
20190151407 | FLAGELLIN RELATED POLYPEPTIDES AND USES THEREOF | 2019-05-23 |
20190151408 | COLICINS FOR TREATING BACTERIAL INFECTIONS | 2019-05-23 |
20190151409 | TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT | 2019-05-23 |
20190151410 | Fusion Protein Between Short Form Rod-Derived Cone Viability Factor and a Hydrophilic Peptide | 2019-05-23 |
20190151411 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC LUNG DISEASES | 2019-05-23 |
20190151413 | COMPOSITIONS AND METHODS FOR ADJOINING TYPE I AND TYPE II EXTRACELLULAR DOMAINS AS HETEROLOGOUS CHIMERIC PROTEINS | 2019-05-23 |
20190151414 | ANTI-COMPLEMENT FACTOR C4/C4B ANTIBODIES AND USES THEREOF | 2019-05-23 |
20190151415 | COMPOSITIONS FOR INHIBITING FIBRIN-VLDL RECEPTOR-DEPENDENT INFLAMMATION AND METHODS OF TREATMENT | 2019-05-23 |
20190151416 | FIBROBLAST GROWTH FACTOR (FGF) 1 PROTEINS WITH GLUCOSE LOWERING ABILITY AND REDUCED MITOGENICITY | 2019-05-23 |
20190151417 | TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN | 2019-05-23 |
20190151418 | COMBINATION OF CALCIUM-PHOSPHATE-CONTAINING POROUS COMPOSITE AND PTH | 2019-05-23 |
20190151419 | DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY | 2019-05-23 |
20190151420 | LYSOSOMAL ACID LIPASE DEFICIENCY COMPOSITIONS AND METHODS | 2019-05-23 |
20190151421 | METHOD FOR PREVENTING OR TREATING LIVER TISSUE DAMAGE AND ASSOCIATED DISEASES | 2019-05-23 |
20190151422 | METHOD FOR PREVENTING AND TREATING CERVICAL EROSION | 2019-05-23 |
20190151423 | DELIVERY SYSTEM COMPRISING A PROTEOLYTIC ENZYME OR EFFECTOR THEREOF FOR USE IN A METHOD FOR ORAL TREATMENT AND USES THEREOF | 2019-05-23 |
20190151424 | CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS | 2019-05-23 |
20190151425 | PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE | 2019-05-23 |
20190151426 | PHOSPHOSERINE CONTAINING COMPOSITIONS FOR IMMUNE TOLERANCE INDUCTION | 2019-05-23 |
20190151427 | Method for Emulsifying a Triepitope Peptide with Montanide and Kits for Performing the Same | 2019-05-23 |
20190151428 | Vaccine Compositions Comprising an Amphipathic Compound, a Neoantigen and a Hydrophobic Carrier, and Methods of Use Thereof | 2019-05-23 |
20190151429 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF TUBERCULOSIS | 2019-05-23 |
20190151430 | ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN | 2019-05-23 |
20190151431 | IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE | 2019-05-23 |
20190151432 | PRRS VIRUS VARIANT, EUROPEAN PRRS VIRUS CDNA CLONE, AND USES THEREOF | 2019-05-23 |
20190151433 | COMPOSITIONS, METHODS AND USES FOR DENGUE VIRUS SEROTYPE-4 CONSTRUCTS | 2019-05-23 |
20190151434 | METHOD OF PROVIDING SAFE ADMINISTRATION OF ADENOVIRAL VECTORS ENCODING A ZIKA VIRUS ANTIGEN | 2019-05-23 |
20190151435 | AUTOLOGOUS AND ALLOGENIC HIV-1 PROTEINS FOR THE TREATMENT OF LATENT HIV-1 INFECTION | 2019-05-23 |
20190151436 | ARENAVIRUSES FOR USE IN THE TREATMENT AND/OR PREVENTION OF TUMORS AND METHOD FOR PRODUCING ARENAVIRUSES WITH (IM-PROVED) TUMOR-REGRESSION PROPERTIES | 2019-05-23 |
20190151437 | COMBINATION PRIME: BOOST THERAPY | 2019-05-23 |
20190151438 | VACCINATION WITH mRNA-CODED ANTIGENS | 2019-05-23 |
20190151439 | DUCK ENTERITIS VIRUS AND THE USES THEREOF | 2019-05-23 |
20190151440 | MOSAIC CONSERVED REGION HIV IMMUNOGENIC POLYPEPTIDES | 2019-05-23 |
20190151441 | NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION | 2019-05-23 |
20190151442 | HEV VACCINE | 2019-05-23 |
20190151443 | Nucleic Acid Molecule Encoding Hepatitis B Virus Core Protein And Vaccine Comprising The Same | 2019-05-23 |
20190151444 | DESENSITIZING MAST CELLS BY CO-PRESENTATION OF ANTIGENS WITH HIGH AFFINITY MAST CELL SIGLEC LIGANDS | 2019-05-23 |
20190151445 | COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES | 2019-05-23 |
20190151446 | MONOMERIC PROTEINS AND USES THEREOF | 2019-05-23 |
20190151447 | COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THEREOF | 2019-05-23 |
20190151448 | PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTS FOR IMPROVED STORAGE AND ADMINISTRATION | 2019-05-23 |
20190151449 | STABILIZED HYPOHALOUS ACID SOLUTIONS | 2019-05-23 |
20190151450 | ANTIBODY FORMULATION | 2019-05-23 |
20190151451 | REDUCED FOAMING VACCINE COMPOSITIONS | 2019-05-23 |
20190151452 | Polymers Including Active Agents | 2019-05-23 |
20190151453 | Drug/polymer Composite Materials And Methods Of Making The Same | 2019-05-23 |
20190151454 | MOLECULAR ASSEMBLY USING AMPHIPATHIC BLOCK POLYMER, AND SUBSTANCE-CONVEYANCE CARRIER USING SAME | 2019-05-23 |